Previous data showing increased relapse of LK2 tumours in SCID mice (that make little or no immunoglobulin) versus Foxn1nu mice (that retain the ability to make IgM), suggested a role for anti-cancer antibodies and neutrophil ADCC in reducing relapse rates [21]. This evidence concerns the gene CD40LG and cancer.